Introduction

8-01

Biosafety of vaccines based on self-replicating recombinant alphavirus

(BIO4-CT98-0031)

8-02

Identification of genes involved in latency and reactivation of Pseudorabies virus, use in biological containment study of viral genomes in pigs

(BIOT-CT91-0297)

8-03

Genetic and immunological safety of DNA vaccines

(BIO4-CT96-0637)

8-04

Biosafety of mucosa-specific RNA-vectors expressing foreign antigens and recombinant antibodies for prevention of disease

(BIO4-CT98-0239)

8-05

Safety of genetically engineered retroviruses used for gene transfer

(BIOT-CT91-0286)

8-06

Monitoring the potential risk linked to the use of modified live viruses for antirabies vaccination of foxes

(BAP-0368/0381/0382)

8-07

Assessment of environmental impact from the use of live recombinant virus vaccines

(BIOT-CT91-0289)